drugset / Trial / NCT02191384

Comparison of Orcinoside With Placebo in Treatment of MDD

NCT02191384 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Orcinoside Capsule in different doses are effective in the treatment of Depression. And to explore the preliminary information of safety and efficacy of Orcinoside Capsule in the Chinese Patients with Depression.

Timeline

Start
2014-07
Primary completion
2016-03-09
Completion
2016-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Orcinoside Unknown 25 mg Oral
Subject Orcinoside Unknown 50 mg Oral
Subject Orcinoside Unknown 100 mg Oral
Subject Orcinoside Unknown 200 mg Oral
Subject Orcinoside Unknown 400 mg Oral
Subject Orcinoside Unknown 600 mg Oral